National Cancer InstituteU.S. National Institutes of Health | www.cancer.gov
U.S. National Institutes of Health www.cancer.gov
Home | About ICSN | Collaborative Projects | Meetings | Cancer Sites | Publications | Contact Us
Cervical Cancer: Mortality Rates | Organization of Screening Programs | Other Characteristics | HPV Vaccine Use

Cervical Cancer Screening Programs in 19 ICSN Countries, 2012: Organization, Policies, and Program Reach*

Region/Country Program Type1 Year Program Began Detection Methods2 Follow-Up Procedure3 Age Groups Covered Recommended Interval for Average Risk Number of Women Screened (2010) Participation Rate (2010)
Australia NS 1991 PC 20-69 2 1,896,259 57.4%
Canada NS 1960 PC, PLC4 HPV-T 21-69 2, 35 4,384,221 35.1-72.0%6
China N 2009 PC, PLC, VILI/VIA 35-59 3 4,000,000 50.0%
Denmark NS 1962 PC, PLC HPV-T 23-49
50-65		 3
5		 400,000 75.0%
Finland N 1963 PC 30-65 5 180,000 70.0%
France O 1990 PC, HPV-P HPV-T 25-27
27-65		 1
3		 550,000 70.0%
Georgia N 2008 PC 25-60 3
Iceland N 1964 PC, PLC 20-39
40-69		 2
4		 25,525 67.0%
Italy NS 1996 PC, PLC, HPV-P HPV-T 25-64 3 1,309,992
Japan NS 1983 PC, PLC 20-70+ 2 343,909 23.9%
Korea N 1988 PC 30-70+ 2 2,357,750 30.3%
Netherlands N 1989 PC, PLC HPV-T 30-60 5 483,310 65.0%
New Zealand N 1991 PC, PLC 20-69 3 426,033 75.2%
Norway N 1995 PC, PLC HPV-T 25-69 3 413,240 63.0%
Poland N 2006 PC 25-59 3 3,290,000 24.0%
Portugal (Alentejo Region) S 2008 PLC 25-64 3 78,063 84.6%
Portugal (Central Region) S 1990 PC 25-54 3 56,000 55.0%
United Kingdom N 1988 PLC HPV-T 25-49
50-64		 3
5		 3,390,000 78.6%
United States O 1991 PC, PLC HPV-T 21-65 3 300,0007

*Data are from a survey of ICSN country representatives, conducted in 2012

1 Program Types:

N (National screening policy with national program implementation)
NS (National screening policy with state/provincial/regional screening program implementation)
S (State/Provincial/Regional screening and program implementation)
O (Other)

2 Detection Methods:

PC (Pap test, conventional cytology)
PLC (Pap test, liquid-based cytology)
HPV-P (HPV test primary screening)

3 Follow-Up Procedure:

HPV-T (HPV test triage)

4 Detection methods vary by provincial program

5 Interval varies by provincial program

6 Represents data from the following provincial screening programs: British Columbia, Manitoba, New Brunswick, Newfoundland, Nova Scotia, Ontario, and Saskatchewan.

7 Denotes an estimate for the number of women screened for cervical cancer who qualify for the National Breast and Cervical Cancer Early Detection Program

Last modified: 03 May 2013
Accessibility Feedback | Privacy Policy & Disclaimers 		National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov: The US government's official web portal Maintained by the Applied Research Program,
Division of Cancer Control and Population Sciences.